1
|
Cui S, Li L, Zhang Y, Lu J, Wang X, Song X, Liu J, Li K. Machine Learning Identifies Metabolic Signatures that Predict the Risk of Recurrent Angina in Remitted Patients after Percutaneous Coronary Intervention: A Multicenter Prospective Cohort Study. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2021; 8:2003893. [PMID: 34026445 PMCID: PMC8132066 DOI: 10.1002/advs.202003893] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/11/2020] [Revised: 01/19/2021] [Indexed: 05/05/2023]
Abstract
Recurrent angina (RA) after percutaneous coronary intervention (PCI) has few known risk factors, hampering the identification of high-risk populations. In this multicenter study, plasma samples are collected from patients with stable angina after PCI, and these patients are followed-up for 9 months for angina recurrence. Broad-spectrum metabolomic profiling with LC-MS/MS followed by multiple machine learning algorithms is conducted to identify the metabolic signatures associated with future risk of angina recurrence in two large cohorts (n = 750 for discovery set, and n = 775 for additional independent discovery cohort). The metabolic predictors are further validated in a third cohort from another center (n = 130) using a clinically-sound quantitative approach. Compared to angina-free patients, the remitted patients with future RA demonstrates a unique chemical endophenotype dominated by abnormalities in chemical communication across lipid membranes and mitochondrial function. A novel multi-metabolite predictive model constructed from these latent signatures can stratify remitted patients at high-risk for angina recurrence with over 89% accuracy, sensitivity, and specificity across three independent cohorts. Our findings revealed reproducible plasma metabolic signatures to predict patients with a latent future risk of RA during post-PCI remission, allowing them to be treated in advance before an event.
Collapse
Affiliation(s)
- Song Cui
- Department of CardiologyBeijing Anzhen HospitalCapital University of Medical SciencesBeijing100029China
| | - Li Li
- Department of CardiologyQufu People's HospitalQufuShandong273100China
| | - Yongjiang Zhang
- Department of CardiologyQufu People's HospitalQufuShandong273100China
| | - Jianwei Lu
- Department of CardiologyQufu People's HospitalQufuShandong273100China
| | - Xiuzhen Wang
- Department of CardiologyQufu People's HospitalQufuShandong273100China
| | - Xiantao Song
- Department of CardiologyBeijing Anzhen HospitalCapital University of Medical SciencesBeijing100029China
| | - Jinghua Liu
- Department of CardiologyBeijing Anzhen HospitalCapital University of Medical SciencesBeijing100029China
| | - Kefeng Li
- School of MedicineUniversity of CaliforniaSan DiegoCA92093USA
| |
Collapse
|
2
|
Napylov A, Reyes‐Garces N, Gomez‐Rios G, Olkowicz M, Lendor S, Monnin C, Bojko B, Hamani C, Pawliszyn J, Vuckovic D. In Vivo Solid‐Phase Microextraction for Sampling of Oxylipins in Brain of Awake, Moving Rats. Angew Chem Int Ed Engl 2020; 59:2392-2398. [DOI: 10.1002/anie.201909430] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2019] [Revised: 10/22/2019] [Indexed: 12/18/2022]
Affiliation(s)
- Alexander Napylov
- Department of Chemistry and BiochemistryConcordia University 7141 Sherbrooke Street West Montreal QC H4B 1R6 Canada
| | - Nathaly Reyes‐Garces
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
- Current address: Restek Corporation Bellefonte PA 16823 USA
| | - German Gomez‐Rios
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
- Current address: Restek Corporation Bellefonte PA 16823 USA
| | - Mariola Olkowicz
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
| | - Sofia Lendor
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
| | - Cian Monnin
- Department of Chemistry and BiochemistryConcordia University 7141 Sherbrooke Street West Montreal QC H4B 1R6 Canada
| | - Barbara Bojko
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
- Current address: Department of Pharmacodynamics and Molecular PharmacologyFaculty of PharmacyCollegium Medicum in BydgoszczNicolaus Copernicus University in Toruń Bydgoszcz Poland
| | - Clement Hamani
- Neuroimaging Research SectionCentre for Addiction and Mental Health 250 College Street Toronto ON M5T 1R8 Canada
- Harquail Centre for NeuromodulationSunnybrook Research InstituteSunnybrook Health Sciences Centre 2075, Bayview Avenue Toronto ON M4N 3M5 Canada
| | - Janusz Pawliszyn
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
| | - Dajana Vuckovic
- Department of Chemistry and BiochemistryConcordia University 7141 Sherbrooke Street West Montreal QC H4B 1R6 Canada
| |
Collapse
|
3
|
Napylov A, Reyes‐Garces N, Gomez‐Rios G, Olkowicz M, Lendor S, Monnin C, Bojko B, Hamani C, Pawliszyn J, Vuckovic D. In Vivo Solid‐Phase Microextraction for Sampling of Oxylipins in Brain of Awake, Moving Rats. Angew Chem Int Ed Engl 2019. [DOI: 10.1002/ange.201909430] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Alexander Napylov
- Department of Chemistry and BiochemistryConcordia University 7141 Sherbrooke Street West Montreal QC H4B 1R6 Canada
| | - Nathaly Reyes‐Garces
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
- Current address: Restek Corporation Bellefonte PA 16823 USA
| | - German Gomez‐Rios
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
- Current address: Restek Corporation Bellefonte PA 16823 USA
| | - Mariola Olkowicz
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
| | - Sofia Lendor
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
| | - Cian Monnin
- Department of Chemistry and BiochemistryConcordia University 7141 Sherbrooke Street West Montreal QC H4B 1R6 Canada
| | - Barbara Bojko
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
- Current address: Department of Pharmacodynamics and Molecular PharmacologyFaculty of PharmacyCollegium Medicum in BydgoszczNicolaus Copernicus University in Toruń Bydgoszcz Poland
| | - Clement Hamani
- Neuroimaging Research SectionCentre for Addiction and Mental Health 250 College Street Toronto ON M5T 1R8 Canada
- Harquail Centre for NeuromodulationSunnybrook Research InstituteSunnybrook Health Sciences Centre 2075, Bayview Avenue Toronto ON M4N 3M5 Canada
| | - Janusz Pawliszyn
- Department of ChemistryUniversity of Waterloo 200 University Avenue Waterloo ON N2L 3G1 Canada
| | - Dajana Vuckovic
- Department of Chemistry and BiochemistryConcordia University 7141 Sherbrooke Street West Montreal QC H4B 1R6 Canada
| |
Collapse
|
4
|
Ungvari Z, Tarantini S, Yabluchanskiy A, Csiszar A. Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular Dysregulation. Front Genet 2019; 10:898. [PMID: 31616477 PMCID: PMC6764114 DOI: 10.3389/fgene.2019.00898] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2019] [Accepted: 08/23/2019] [Indexed: 12/12/2022] Open
Abstract
Late life depression is an important public health problem, which associates with increased risk of morbidity and mortality. Selective serotonin reuptake inhibitors (SSRIs), including fluoxetine, are often prescribed to treat geriatric depression. There is increasing evidence that fluoxetine and other SSRIs exert a wide range of cardiovascular side effects. Furthermore, there is evidence that aging may increase plasma level of SSRIs. In this overview, the potential role of side effects of treatment with fluoxetine and other SSRIs in the pathogenesis of age-related cardiovascular diseases, including atherogenesis, cardiac pathologies, and cerebromicrovascular impairment, is discussed.
Collapse
Affiliation(s)
- Zoltan Ungvari
- Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
- Translational Geroscience Laboratory, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
- Department of Medical Physics and Informatics, Faculty of Medicine and Faculty of Science and Informatics, University of Szeged, Szeged, Hungary
- Department of Public Health, Semmelweis University, Budapest, Hungary
| | - Stefano Tarantini
- Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
- Translational Geroscience Laboratory, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
- Department of Medical Physics and Informatics, Faculty of Medicine and Faculty of Science and Informatics, University of Szeged, Szeged, Hungary
- Department of Public Health, Semmelweis University, Budapest, Hungary
| | - Andriy Yabluchanskiy
- Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
- Translational Geroscience Laboratory, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
| | - Anna Csiszar
- Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
- Translational Geroscience Laboratory, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
- Department of Medical Physics and Informatics, Faculty of Medicine and Faculty of Science and Informatics, University of Szeged, Szeged, Hungary
| |
Collapse
|
5
|
Yi M, Cho SA, Min J, Kim DH, Shin JG, Lee SJ. Functional characterization of a common CYP4F11 genetic variant and identification of functionally defective CYP4F11 variants in erythromycin metabolism and 20-HETE synthesis. Arch Biochem Biophys 2017; 620:43-51. [DOI: 10.1016/j.abb.2017.03.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2016] [Revised: 03/08/2017] [Accepted: 03/19/2017] [Indexed: 12/31/2022]
|
6
|
Piekos S, Pope C, Ferrara A, Zhong XB. Impact of Drug Treatment at Neonatal Ages on Variability of Drug Metabolism and Drug-drug Interactions in Adult Life. ACTA ACUST UNITED AC 2017; 3:1-9. [PMID: 28344923 DOI: 10.1007/s40495-016-0078-6] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
PURPOSE OF REVIEW As the number of patients taking more than one medication concurrently continues to increase, predicting and preventing drug-drug interactions (DDIs) is now more important than ever. Administration of one drug can cause changes in the expression and activity of drug metabolizing enzymes (DMEs) and alter the efficacy or toxicity of other medications that are substrates for these enzymes, resulting in a DDI. In today's medical practice, potential DDIs are evaluated based on the current medications a patient is taking with little regard to drugs the patient has been exposed to in the past. The purpose of this review is to discuss potential impacts of drug treatment at neonatal ages on the variability of drug metabolism and DDIs in adult life. RECENT FINDINGS Existing evidence from the last thirty years has shown that exposure to certain xenobiotics during neonatal life has the potential to persistently alter DME expression through adult life. With recent advancements in the understanding of epigenetic regulation on gene expression, this phenomenon is resurfacing in the scientific community in hopes of defining possible mechanisms. Exposure to compounds that have the ability to bind nuclear receptors and trigger epigenetic modifications at neonatal and pediatric ages may have long-term, if not permanent, consequences on gene expression and DME activity. SUMMARY The information summarized in this review should challenge the way current healthcare providers assess DDI potential and may offer an explanation to the significant interindividual variability in drug metabolism that is observed among patients.
Collapse
Affiliation(s)
- Stephanie Piekos
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, USA
| | - Chad Pope
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, USA
| | - Austin Ferrara
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, USA
| | - Xiao-Bo Zhong
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, USA
| |
Collapse
|
7
|
Ghosh C, Hossain M, Solanki J, Dadas A, Marchi N, Janigro D. Pathophysiological implications of neurovascular P450 in brain disorders. Drug Discov Today 2016; 21:1609-1619. [PMID: 27312874 DOI: 10.1016/j.drudis.2016.06.004] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2016] [Revised: 04/14/2016] [Accepted: 06/06/2016] [Indexed: 01/12/2023]
Abstract
Over the past decades, the significance of cytochrome P450 (CYP) enzymes has expanded beyond their role as peripheral drug metabolizers in the liver and gut. CYP enzymes are also functionally active at the neurovascular interface. CYP expression is modulated by disease states, impacting cellular functions, detoxification, and reactivity to toxic stimuli and brain drug biotransformation. Unveiling the physiological and molecular complexity of brain P450 enzymes will improve our understanding of the mechanisms underlying brain drug availability, pharmacological efficacy, and neurotoxic adverse effects from pharmacotherapy targeting brain disorders.
Collapse
Affiliation(s)
- Chaitali Ghosh
- Cerebrovascular Research, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA; Department of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA; Department of Molecular Medicine, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
| | - Mohammed Hossain
- Cerebrovascular Research, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA; Department of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA
| | | | - Aaron Dadas
- The Ohio State University, Columbus, OH, USA
| | - Nicola Marchi
- Cerebrovascular Mechanisms of Brain Disorders, Department of Neuroscience, Institute of Functional Genomics (CNRS/INSERM), Montpellier, France
| | - Damir Janigro
- Flocel Inc. and Case Western Reserve University, Cleveland, OH, USA
| |
Collapse
|